Pa. Schulte et Mh. Sweeney, ETHICAL CONSIDERATIONS, CONFIDENTIALITY ISSUES, RIGHTS OF HUMAN-SUBJECTS, AND USES OF MONITORING DATA IN RESEARCH AND REGULATION, Environmental health perspectives, 103, 1995, pp. 69-74
Biomarkers are potentially powerful tools for use in research and regu
lation. Their derivation from biologic specimens collected from human
subjects does, however, present many ethical implications. Ethical iss
ues are relevant in almost each facet of human biomarker research stud
ies: design, identification and recruitment of subjects, handling and
use of the data, and interpretation and communication of results. Rese
archers also face a number of dilemmas when considering the use of hum
an biologic specimens and new biomarkers. The mere fact that such mark
ers are the result of measurements in human specimens gives the appear
ance of being more accurate than traditional sources of information su
ch as questionnaires or environmental monitoring; yet, this may not al
ways be the case. The meaning of the results of biomarker studies may
be unclear because the purpose of the study is usually for research ra
ther than clinical purposes. There generally are no established normal
ranges for biomarkers and the interpretation of findings are often di
fficult. Researchers may not communicate these results to subjects or
consider followup action because the task may be too difficult or unde
fined, or the reaction of the subject cannot be anticipated. A wide ra
nge of practices in this regard exists among researchers. Many questio
ns remain unanswered about the use of biologic specimens. These includ
e questions of ownership and access to specimens. Related to this is t
he question of whether specimens collected for one research purpose ca
n be used for an entirely different research purpose. This is still an
open question. Researchers and regulators may not be aware of the pot
ential for biomarker information to affect the lives of subjects and t
heir families without sufficient protection of personally identifiable
data and regulation of its use. it is incumbent on researchers to con
sider these human subject questions whenever they are using human spec
imens or biomarkers.